Photoradiation therapy of rat liver cancer - Protection of the normal liver by indocyanine green.

大鼠肝癌的光放射治疗——吲哚菁绿对正常肝脏的保护。

基本信息

  • 批准号:
    60480211
  • 负责人:
  • 金额:
    $ 1.66万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1986
  • 项目状态:
    已结题

项目摘要

An application of photoradiation therapy to hepatocellular carcinoma (HCC) has been difficult because hematoporphyrin derivatives (HpD) accumulate not only in cancer cells but also in normal hepatocytes and, hence, laser irradiation causes injuries in both tissues. Protection of the normal liver tissue from laser phototoxicity was demonstrated using indocyanine green (ICG) as a protective agent. In vitro, argon laser irradiation decolored green tint of ICG much faster in solutions containing HpD than those without, suggesting that ICG captured excited oxygen from HpD. Degeneration of Chang hepatocytes induced by HpD and laser irradiation was protected by an addition of ICG into the medium. In vivo, laser irradiation of the rat liver surface caused hyperemia when HpD was injected two days before, while the hyperemia was much milder in rats added with ICG injection 10 minutes before the irradiation. ICG injected into rat HCC accumulated only in the normal liver tissue. Laser irradiation of rat HCC preinjected with both HpD and ICG destroyed only cancer tissue, preserving the surrounding liver tissue.Both in vitro and in vivo results suggest that ICG has a scavenger effect against excited oxygen and it might be used as a protective agent in photoradiation therapy of HCC.
由于血卟啉衍生物(HpD)不仅在癌细胞中而且在正常肝细胞中积累,因此,激光照射导致两种组织的损伤,因此光辐射治疗肝细胞癌(HCC)的应用一直是困难的。用吲哚菁绿色(ICG)作为保护剂,对正常肝组织的激光光毒性有保护作用。在体外,氩激光照射脱色绿色色调的ICG在溶液中含有HpD比那些没有更快,这表明ICG捕获HpD的激发氧。ICG对HpD和激光诱导的Chang肝细胞变性有保护作用。在体内,激光照射大鼠肝表面引起充血时,注射HpD两天前,而充血的大鼠在照射前10分钟加入ICG注射轻得多。注射到大鼠HCC中的ICG仅在正常肝组织中积累。激光照射预先注射HpD和ICG的大鼠肝癌,仅破坏癌组织,而保留周围肝组织,体内外实验结果表明ICG对激发态氧有清除作用,可作为光辐射治疗肝癌的保护剂。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kitak,et al: Gastroenterologia Japonica. 22. (1987)
Kitak 等人:日本胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kita K, et al.: "Photoradiation therapy of rat liver cancer - Protection of the normal liver by indocyanine green." Gastroenterologia Japonica. 22. (1987)
Kita K 等人:“大鼠肝癌的光放射治疗 - 吲哚菁绿保护正常肝脏。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
喜田恵治ほか: 薬理と治療. 14. 353-354 (1986)
Keiji Kida 等人:药理学和治疗。14. 353-354 (1986)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kita K, et al.: "An application of photoradiation therapy in experimentally induced rat hepatocellular carcinoma and protection of noncancerous parts by indocyanine green." Japanese Pharmacology & Therapeutics. 14. 353-354 (1986)
Kita K 等人:“光放射疗法在实验诱导的大鼠肝细胞癌中的应用以及吲哚菁绿对非癌部分的保护。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITOSHIMA Tatsuya其他文献

ITOSHIMA Tatsuya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
  • 批准号:
    490038
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Operating Grants
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
通过冷冻消融调节肝癌的免疫代谢相互作用
  • 批准号:
    10647494
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
  • 批准号:
    10699190
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
儿童和成人肝癌中肿瘤与宿主的相互作用
  • 批准号:
    10100127
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    EU-Funded
Engineering and preliminary safety assessment of an RNA trans-splicing therapeutic vector for liver cancer.
肝癌 RNA 反式剪接治疗载体的工程设计和初步安全性评估。
  • 批准号:
    10075525
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant for R&D
Modelling cargo loaded macrophage trafficking across liver endothelium: a new approach to drug delivery in liver cancer.
模拟负载巨噬细胞穿过肝内皮的运输:肝癌药物输送的新方法。
  • 批准号:
    2890431
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Studentship
Development of all-round combination immunotherapy for advanced liver cancer
晚期肝癌全方位联合免疫疗法的研发
  • 批准号:
    23H02886
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel circulating biomarker digital scores for assessing treatment response in liver cancer
用于评估肝癌治疗反应的新型循环生物标志物数字评分
  • 批准号:
    10651050
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
Liquid biopsy and radiomics for liver cancer surveillance
用于肝癌监测的液体活检和放射组学
  • 批准号:
    10736720
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
靶向 LIFR-LCN2 通路改善肝癌治疗
  • 批准号:
    10583188
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了